ClinicalTrials.gov
ClinicalTrials.gov Menu

DS-Connect {TM}: The Down Syndrome Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01950624
Recruitment Status : Recruiting
First Posted : September 25, 2013
Last Update Posted : August 31, 2018
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) )

September 21, 2013
September 25, 2013
August 31, 2018
September 21, 2013
August 16, 2019   (Final data collection date for primary outcome measure)
  • To identify individuals with DS who may be eligible for research studies or new clinical trials, based on specific information about their diagnosis and health history. [ Time Frame: 1 year ]
  • To determine the prevalence and various phenotypic manifestations of DS. [ Time Frame: 1 year ]
Methothelioma Sample Acquisition [ Time Frame: 20 years ]
Complete list of historical versions of study NCT01950624 on ClinicalTrials.gov Archive Site
  • Aggregate data from individuals with DS globally. Enable researchers to use de-identified data to analyze the etiology, natural history, and/or treatment effectiveness in DS. Help medical professionals improve treatments for those with DS. [ Time Frame: 1 year ]
  • Study why individuals with DS have different symptoms. Allow individuals with DS and their families to look at their information in DS-Connect and compare it to de-identified information from other participants in the Registry. [ Time Frame: 1 year ]
Not Provided
Not Provided
Not Provided
 
DS-Connect {TM}: The Down Syndrome Registry
DS-Connect [TM]: The Down Syndrome Registry

Objective: The development of a patient registry for Down syndrome (DS) was identified as a priority in the 2007 Down Syndrome Research Plan. Under the auspices of the Down Syndrome Consortium, founded in 2011 as a public-private partnership between the NIH and DS advocacy organizations, NICHD awarded a contract in 2012 to create a patient-focused online registry to facilitate research participation by individuals with DS. Two advisory boards, composed of advocates, family members, clinicians, researchers, and other relevant parties, have been involved in the development of the registry materials.

Study Population: Individuals with DS (including those with mosaic DS and partial trisomy 21)

Design: DS-Connect (TM) is an online survey tool designed to collect demographic data and health information from individuals with DS.

Outcome measures: The purposes of DS-Connect (TM) are:

  1. To identify the various phenotypic manifestations of DS.
  2. To identify individuals with DS who may be eligible for research studies or new clinical trials, based on specific information about their diagnosis and health history.

Objective: The development of a patient registry for Down syndrome (DS) was identified as a priority in the 2007 Down Syndrome Research Plan. Under the auspices of the Down Syndrome Consortium, founded in 2011 as a public-private partnership between the NIH and DS advocacy organizations, NICHD awarded a contract in 2012 to create a patient-focused online registry to facilitate research participation by individuals with DS. Two advisory boards, composed of advocates, family members, clinicians, researchers, and other relevant parties, have been involved in the development of the registry materials.

Study Population: Individuals with DS (including those with mosaic DS and partial trisomy 21)

Design: DS-Connect (TM) is an online survey tool designed to collect demographic data and health information from individuals with DS.

Outcome measures: The purposes of DS-Connect (TM) are:

  1. To identify the various phenotypic manifestations of DS.
  2. To identify individuals with DS who may be eligible for research studies or new clinical trials, based on specific information about their diagnosis and health history.
Observational
Observational Model: Cohort
Time Perspective: Other
Not Provided
Not Provided
Not Provided
Not Provided
Down Syndrome
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
100000
Same as current
August 16, 2020
August 16, 2019   (Final data collection date for primary outcome measure)
  • INCLUSION CRITERIA:
  • Adults (at least 18 years of age) with a diagnosis of DS (including mosaic DS or partial trisomy 21) who are capable of providing consent to participate, or for whom a legally authorized representative (LAR) may give permission on behalf of the individual to participate. Adults with DS who cannot consent for themselves but can provide assent would need to provide assent to their LAR.
  • Children (up to age 18 years of age) with a diagnosis of DS. Parents/guardians may enter registry information and give permission to participate on behalf of their child; if the child is over 7 years of age and able to provide assent, they must do so. (Note: Once a child has reached age 18, he or she will be prompted to re-enroll into the registry as an adult, if he/she is able to provide informed consent or with the consent of his/her LAR if unable to re-enroll themselves.)
  • Children with DS (between the ages of 7 and 18 years) will be asked to provide their assent to register.

No individuals with DS will be excluded from taking part in DS-Connect based on age, race,

ethnicity, or gender.

EXCLUSION CRITERIA:

  • A person who does not have a diagnosis of DS (or mosaic DS or partial trisomy 21)
  • Adults with DS who are not capable of providing informed consent or assent to participate and do not have a Legally Authorized Representative who can do so. In the case where an adults with DS is able to provide assent but does not do so, that adult will be excluded.
  • A participant, parent, and/or LAR who cannot provide consent or does not read or understand a language that is available for the registry, either English or Spanish.
  • A child with DS (between the ages of 7 and 18 years) who is capable of providing assent but does not do so.
  • A child under the age of 18 years whose parents share joint custody and one parent indicates that they do not consent to the child s participation.
Sexes Eligible for Study: All
Child, Adult, Older Adult
No
Contact: Melissa A Parisi, M.D. (301) 827-1448 parisima@mail.nih.gov
United States
 
 
NCT01950624
999913201
13-CH-N201
Not Provided
Not Provided
Not Provided
National Institutes of Health Clinical Center (CC) ( Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) )
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not Provided
Principal Investigator: Melissa A Parisi, M.D. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institutes of Health Clinical Center (CC)
May 30, 2018